Predicting the Safety and Effectiveness of Inferior Vena Cava Filters (PRESERVE)

Conditions

Diseases of the Cardiovascular System

What is the purpose of this trial?

PRESERVE is a multi-center, prospective, open-label, non-randomized investigation of commercially available IVC filters from 7 manufacturers placed in subjects for the prevention of pulmonary embolism (PE). This study will enroll approximately 2,100 IVC filter subjects at up to 60 sites in the US. All treated subjects will be evaluated at procedure, 3-months, 6-months (phone), 12-months, 18-months (phone), and 24-months post-procedure. The primary objective of this investigational device exemption (IDE) clinical investigation is to evaluate the safety and effectiveness of the commercially available IVC filters (retrievable and permanent) in subjects with clinical need for mechanical prophylaxis of PE with an IVC filter.

  • Trial with
    New England Research Institute
  • Start Date
    03/22/2016
  • End Date
    04/30/2018

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8348

Trial Image

For more information about this study, contact:

Jacqueline Gamberdella

  • Last Updated
    02/22/2018
  • Study HIC
    #1508016319